Steven Yecies
Managing Partner at Kain Capital
San Francisco Bay Area
Overview
Work Experience
Founder and Managing Partner
2025 - Current
New Dimensions Health is focused exclusively on making investments of $50-$250 million in healthcare information technology and healthcare services companies. In special situations we do company creation and spin-outs with key strategic partners. Portfolio companies provide technology or service delivery innovations that enhance access to care, improve the healthcare experience, lower costs and improve outcomes for patients. We are a global investor and primarily focused on growing companies with established customers, revenue and product. We partner with entrepreneurs, founders, management and providers to work in alignment toward significant growth. We build new dimensions (business models, markets, geograpgihies) on top of strong platforms and foundations
Affiliated Partner
2025
As an Affiliated Partner I will continue to manage Kain portfolio investments that I originated as a board member.
Managing Partner
2022 - 2025
Kain Capital invests exclusively in healthcare services and healthcare IT companies. Kain partners with entrepreneurs and physicians to build transformative healthcare companies to improve how healthcare is delivered to patients. Kain has not utilized debt in its seven platform investments and focuses on creating significant growth with its partners. Kain focuses on technology enablement of its portfolio companies to both enhance existing operations and enable transformation to risk based business models. Kain has more than doubled its assets under management and internal staff since I joined the firm as one of two Managing Partners.
Non-Executive Chairman and Board Member
2022
Leading provider of primary care services in the Arizona market. Offers high quality affordable care in a manner that is highly convenient to patients with high traffic retail locations that are open seven days a week. MDN also provides care through video visits and provider in home visits.
MyDr NOW is a Health Care Company On demand.
Non-Executive Chairman of the Board
2022 - 2025
PERA Holdings is a centralized national, operating company that acquires and operates outstanding regional hospice and palliative care companies.
Consultant
2018 - 2022
Continued to serve as OrbiMed representative on Board of Directors where I played a primary role in originating and managing the investment.
Venture Partner
2013 - 2018
Served as a Venture Partner at OrbiMed responsible for our health care IT and health care services investments. I work with OrbiMed colleagues in sourcing, executing, and managing private investments in these sub-sectors. To date OrbiMed has made several health care IT and services investments across its global private funds. OrbiMed Advisors LLC is a leading investment firm dedicated exclusively to the healthcare sector. OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational companies, in a variety of sub-sectors including biopharmaceuticals, medical devices and health IT. OrbiMed’s team of professionals manages a series of private equity funds, public equity funds, royalty funds and other investment vehicles. The firm operates out of five offices – New York, Tel Aviv, San Francisco, Shanghai and Mumbai. http://www.orbimed.com
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals for medical devices and diagnostics.
Board Member
2014 - 2022
Served as Board Member for TigerConnect (formerlyTigerText) from January 2014 through February 2022. During this tenure the company's revenues increased by 20X and post money valuation by more than 10X. TigerConnect is healthcare's most advanced connected clinical communication platform. The company is the market leader among US hospitals and integrated health systems for providing integrated enterprise communications and automated work flow.
TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.
Raised $433,900,000.00 from Vista Equity Partners.
Board Member
2015 - 2022
Sikka is a leading marketplace for over 25,000 dental and veterinarian practices and hundreds of industry suppliers of products and services. Sikka integrates to almost all electronic clinical records and financial management systems of the practices. The company also has a robust information services business.
Chief Executive Officer
2020 - 2021
Javelin Oncology introduces a new capability to precision immune medicine. This enables us to predict patient responses to treatment, significantly reducing the time and resources required to launch new immunotherapies. We apply our platform both to create novel therapies in our own labs and as a service to other life sciences companies to help them advance their discovery and development of immuno-oncology therapies. Led licensing of lead assets to leading European Biotech company before exiting company.
Board Member
2013 - 2018
Practice Fusion is the leading provider of cloud based electronic medical records and is the fourth largest EMR provider in the United States. Practice Fusion was sold to AllScripts (MDRX) in January, 2018
Practice Fusion provides a free web-based electronic health record system and medical practice management technology to physicians.
Raised $157,519,998.00 from Oakhouse Partners and ORIX Growth Capital.
Board Member
2016 - 2018
Augmedix is a leading provider of scribing services and automated work flow solutions to providers at many of the leading integrated health systems. Augmedix has offices and partners in the United Sates, Bangladesh, India, Sri Lanka and the Dominican Republic.
Medical documentation, Point-of-care notifications, Structured data, Open ecosystem
Raised $161,700,000.00 from HCA Healthcare and Redmile Group.